Open access
3,472
Views
7
CrossRef citations to date
0
Altmetric
Report
Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptor
Xiaoshan Mina Departments of Therapeutics Discovery, Amgen Research, South San Francisco, CA, USACorrespondence[email protected]
https://orcid.org/0000-0003-2229-5455View further author information
Junming Yieb Department of Cardiometabolic Disorders, Amgen Research, Thousand Oaks, CA, USA
https://orcid.org/0000-0003-3935-7114View further author information
Jinghong Wangc Department of Cardiometabolic Disorders, Amgen Research, South San Francisco, CA, USAView further author information
, Ben C. Chunga Departments of Therapeutics Discovery, Amgen Research, South San Francisco, CA, USA
https://orcid.org/0000-0002-8920-2308View further author information
Ching-Shin Huanga Departments of Therapeutics Discovery, Amgen Research, South San Francisco, CA, USA
https://orcid.org/0000-0002-6435-9309View further author information
Haoda Xua Departments of Therapeutics Discovery, Amgen Research, South San Francisco, CA, USA
https://orcid.org/0000-0002-5995-316XView further author information
Jie Yangd Department of Therapeutic Discovery, Amgen Research, Thousand Oaks, CA, USAView further author information
, Liying Dengb Department of Cardiometabolic Disorders, Amgen Research, Thousand Oaks, CA, USA
https://orcid.org/0000-0002-7729-2772View further author information
Joanne Lind Department of Therapeutic Discovery, Amgen Research, Thousand Oaks, CA, USAView further author information
, Qing Chend Department of Therapeutic Discovery, Amgen Research, Thousand Oaks, CA, USA
https://orcid.org/0000-0003-2425-9378View further author information
Christina M. Abbottd Department of Therapeutic Discovery, Amgen Research, Thousand Oaks, CA, USA
https://orcid.org/0000-0003-2496-3787View further author information
Caroline Gundelc Department of Cardiometabolic Disorders, Amgen Research, South San Francisco, CA, USA
https://orcid.org/0000-0002-6718-812XView further author information
Stephen A. Thibaulta Departments of Therapeutics Discovery, Amgen Research, South San Francisco, CA, USA
https://orcid.org/0000-0002-6660-7919View further author information
Tina Mengd Department of Therapeutic Discovery, Amgen Research, Thousand Oaks, CA, USAView further author information
, Darren L. Batesd Department of Therapeutic Discovery, Amgen Research, Thousand Oaks, CA, USA
https://orcid.org/0000-0003-3960-7400View further author information
David J. Lloydb Department of Cardiometabolic Disorders, Amgen Research, Thousand Oaks, CA, USAView further author information
, Murielle M. Véniantb Department of Cardiometabolic Disorders, Amgen Research, Thousand Oaks, CA, USAView further author information
& Zhulun Wanga Departments of Therapeutics Discovery, Amgen Research, South San Francisco, CA, USACorrespondence[email protected]
https://orcid.org/0000-0002-1815-6391View further author information
Article: 1710047
|
Received 02 Aug 2019, Accepted 19 Dec 2019, Published online: 12 Jan 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.